Artificial Intelligence

Artificial intelligence is progressively entering pharmaceutical formulation workflows, particularly in areas such as compatibility screening, dissolution profile prediction, formulation optimization...

Abstract Functional excipients are increasingly recognized as active components in drug formulations because they can influence drug stability, solubility, release...

Abstract Background/Objectives: The integration of artificial intelligence (AI) into pharmaceutical development has the potential to accelerate early-stage formulation design. In this...

AI in pharmaceutical drug product design is, in 2026, a decision-support technology, not autonomous formulation. The most mature tools combine...

The pharmaceutical industry continues to evolve under the pressure of medication affordability, regulatory constraints, and growing environmental expectations. In 2025,...

Abstract The rapid development of artificial intelligence (AI) and the increasing demand for the modernization of Chinese herbal medicine (CHM)...

Abstract The pharmaceutical industry is undergoing a rapid digital transformation. These changes are reshaping drug substance and drug product development...

Abstract Pharmaceutical formulations comprise active pharmaceutical ingredients (APIs) and excipients, the latter of which can significantly influence drug stability. Compatibility...

Abstract Background/Objectives: Tablet development requires simultaneous optimization of multiple quality attributes under limited experimental budgets, yet formulation–property relationships are highly nonlinear...

Abstract Background/Objectives: The development of extended-release oral dosage forms remains a complicated and time consuming process, particularly during early formulation...